FOLD - Company ID 0001178879
The table below shows AMICUS THERAPEUTICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $214.01M | $213.75M | $246.99M | $148.81M | $245.20M | $163.24M |
| Short-term investments | $79.53M | $36.19M | $39.21M | $144.78M | $237.30M | $320.03M |
| Receivables | $115.31M | $101.10M | $87.63M | $66.20M | $52.67M | $46.92M |
| Inventory | $228.82M | $118.78M | $59.70M | $23.82M | $26.82M | $19.56M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $676.17M |
| $504.74M |
| $483.06M |
| $423.82M |
| $596.83M |
| $579.47M |
| Property, plant & equipment | $27.11M | $29.38M | $31.67M | $30.78M | $42.50M | $43.86M |
| Goodwill | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M |
| Total assets | $949.87M | $785.03M | $777.88M | $724.17M | $905.14M | $886.52M |
| Accounts payable | $28.63M | $12.95M | $15.12M | $15.41M | $21.51M | $17.06M |
| Total current liabilities | $237.83M | $148.70M | $167.69M | $139.02M | $145.97M | $129.68M |
| Long-term debt | $392.66M | $390.11M | $387.86M | $391.99M | $389.36M | $389.25M |
| Total liabilities | $675.63M | $590.99M | $617.71M | $601.12M | $597.77M | $600.14M |
| Retained earnings | -$2.77B | -$2.74B | -$2.68B | -$2.53B | -$2.30B | -$2.05B |
| Total equity | $274.24M | $194.04M | $160.17M | $123.05M | $307.37M | $286.38M |